A mutated HLA-A*0101 allele in the colorectal cell line HCA-7

Tissue Antigens

Volumn 66, Issue 3, 2005, Pages 231-237

  Bicknell, D C ^a   Bodmer, W F ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; HLA class I; Missmatch repair; Mutation

Indexed keywords

CYTOSINE; HLA A1 ANTIGEN; HLA A2 ANTIGEN; DNA; HLA A ANTIGEN; HLA A*0101 ANTIGEN, HUMAN; HLA A*0201 ANTIGEN; HLA-A*0101 ANTIGEN, HUMAN; HLA-A*0201 ANTIGEN; PRIMER DNA; RNA;

ALLELE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; COLORECTAL CANCER; CONTROLLED STUDY; DNA EXTRACTION; HUMAN; HUMAN CELL; ISOELECTRIC FOCUSING; MISMATCH REPAIR; MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; 3' UNTRANSLATED REGION; BASE MISPAIRING; COLORECTAL TUMOR; DNA REPAIR; DNA SEQUENCE; EXON; GENE FREQUENCY; GENETICS; METABOLISM; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PROMOTER REGION; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ALLELES; BASE PAIR MISMATCH; CELL LINE, TUMOR; CLONING, MOLECULAR; COLORECTAL NEOPLASMS; CYTOSINE; DNA; DNA PRIMERS; DNA REPAIR; EXONS; GENE FREQUENCY; HLA-A ANTIGENS; HUMANS; ISOELECTRIC FOCUSING; MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SEQUENCE ANALYSIS, DNA;

EID: 24144480907     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2005.00456.x     Document Type: Article

References (30)

1. Nilsson K, Evrin P-E, Welsh KI. Production of beta-2 microglobulin by normal and malignant human cell lines and peripheral lymphocytes. Transplant Rev 1974: 21: 53-84.
2. Arce-Gomez B, Jones EA, Barnstable CJ, Solomon E, Bodmer WF. The genetic control of HLA-A and B antigens in somatic cell hybrids: Requirement for Beta-2 Microglobulin. Tissue Antigens 1978: 11: 96-112.
3. Brodsky FM, Parham P, Barnstable CJ, Crumpton MJ, Bodmer WF. Monoclonal Antibodies for Analysis of the HLA System. Immunol Rev 1979: 47: 3-61.
4. Travers P, Arklie JL, Trowsdale J, Patillo RA, Bodmer WF. Lack of expression of HLA-ABC antigens in choriocarcinoma and other human cell lines. Research Frontiers in Aging and Cancer Bethesda, Maryland USA: NCI, 1982:175-80.
5. Paterson AC, Sciot R, Kew MC, Callea F, Dusheiko GM, Desmet VJ. HLA expression in human hepatocellular carcinomas. Br J Cancer 1988: 57: 369-73.
6. Kabawat SE, Bast RC Jr, Welch WR, Knapp RC, Bhan AK. Expression of major histocompatibility antigens and nature of inflammatory infiltrate in ovarian neoplasms. Int J Cancer 1983: 32: 547-54.
7. Moller P, Herrmann B, Moldenhauer G, Momburg F. Defective expressioin of MHC class I antigens is frequent in B-cell lymphomas of high grade malignancy. Int J Cancer 1987: 40: 32-9.
8. Richman P. Monoclonal antibodies for the study of differentiation in normal and neoplastic human colorectal epithelium. University of London, 1987.
9. Lopez-Nevot MA, Esteban F, Ferron A et al. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA anitgens on colorectal, gastric and laryngeal carcinomas. Br J Cancer 1989: 59: 221-6.
10. Smith MEF, Marsh SG, Bodmer JG, Gelsthorpe K, Bodmer WF. Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia. Proc Natl Acad Sci USA 1989: 86: 5557-61.
11. Kaklamanis L, Gatter KC, Hill AB et al. Loss of HLA Class-1 Alleles, Heavy Chains and β-2Microglobulin in Colorectal cancer. Int J Cancer 1992: 51: 379-85.
12. Smith MEF, Bodmer WF, Bodmer JG. Selective Loss of HLA-A,B,C Locus Products in Colorectal Adenocercinoma. Lancet, 1988: 1: 824.
13. Goodfellow P, Jones EA, Van Heyningen V, Solomon E, Bobrow M. The Beta-2 Microglobulin gene is on chromosome 15 and not in the HLA region. Nature 1975: 254: 5497-8.
14. Rosa F, Berissi H, Weissenbach J, Maroteaux L, Fellous M, Revel M. The beta-2 microglobulin mRNA in human Daudi cells has a mutated initiation codon but is still inducible by interferon. EMBO J 1983: 2: 239-43.
15. Bicknell DC, Rowan A, Bodmer WF. Beta 2-microglobulin gene mutations, a study of established colorectal cell lines and fresh tumors. Proc Natl Acad Sci USA, 1994: 91: 4751-6.
16. Cabrera CM, Jimenez P, Cabrera T, Esparza C, Ruiz-Cabello F, Garrido F. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: B2-microglobulin inactivation in MSI-positive tumours and LMP7/TAP2 downregulation in MSI-negative tumours. Tissue Antigens 2003: 61: 211-9.
17. Momburg F, Koch S. Selective loss of Beta-2 microglobulin mRNA in human colon carcinoma. J Exp Med 1989: 169: 309-14.
18. Browning M, Petronzelli F, Bicknell D et al. Mechanisms of loss of HLA class I expression on colorectal tumor cells. Tissue Antigens 1996: 47: 364-71.
19. Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG, Bodmer WF. Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc Natl Acad Sci USA 1993: 90: 2842-5.
20. Kirkland SC. Dome formation by a human colonic adenocarcinoma cell line (HCA-7). Cancer Res 1985: 45: 3790-5.
21. Yang SY. A standardized method for detection of HLA-A and HLA-B alleles by one dimensional isoelectric focusing (IEF) gel electrophoresis. In: Dupont B, ed. Immunobiology of HLA Histocompatibility Testing 1987, Vol. I. New York: Springer-Verlag, 1989: 332-335.
22. Barnstable CJ, Bodmer WF, Brown G et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens - new tools for genetic analysis. Cell 1978: 14: 9-20.
23. Tonks S, Marsh SG, Bunce M, Bodmer JG. Molecular typing for HLA class I using ARMS-PCR: further developments following the 12th International Histocompatibility Workshop. Tissue Antigens 1999: 53: 175-83.
24. Bartlett S, Straub J, Tonks S, Wells RS, Bodmer JG, Bodmer WF. Alkaline-mediated differential interaction (AMDI): a simple automatable single-nucleotide polymorphism assay. Proc Natl Acad Sci USA 2001: 98: 2694-7.
25. Bunce M, Procter J, Welsh KI. A DNA-based detection and screening system for identifying HLA class I expression variants by sequence-specific primers. Tissue Antigens 1999: 53: 498-506.
26. Smith MEF. Immunoregulatory molecules in tumours University of London, 1990.
27. Laforet M, Froelich N, Parissiadis A et al. A nucleotide insertion in exon 4 is reponsible for the absence of expression of an HLA-A*01 allele. Tissue Antigens 1997: 50: 347-50.
28. Magor KE, Taylor EJ, Shen SY et al. Natural inactivation of a common HLA allele (A*2402) has occured on at least three separate occassions. J Immunol 1997: 158: 5242-50.
29. Parham P. Filling in the blanks. Tissue Antigens 1997: 50: 318-22.
30. Branch P, Bicknell DC, Rowan A, Bodmer WF, Karran P. Immune surveillance in colorectal carcinoma [letter]. Nat Genet 1995: 9: 231-2.